A web-blog (formerly known as Stu's Views and MS News), now published by MS Views and News, a patient advocacy organization. The information on this blog helps to Empower those affected by Multiple Sclerosis globally, with education, information, news and community resources.
~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--October 15, 2013--
BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it will initiate a pre-clinical study for Multiple Sclerosis (MS) at the Hebrew University Hadassah Medical Center's SPF-grade animal laboratory in Jerusalem. The study was approved by the Institutional Animal Care and Use Committee (IACUC) of the Hebrew University.
Based on promising pre-clinical data published by the Company's Chief Scientist, Prof. Daniel Offen of Tel Aviv University, BrainStorm will conduct further studies using the Experimental Autoimmune Encephalomyelitis (EAE) animal model to evaluate MS as an additional indication for its NurOwn technology. Professor Dimitrios Karussis and Dr. Ibrahim Kassis, who have published extensively on pre-clinical research using the EAE model, will be the Principal Investigators of the study.
Prof. Karussis, a Key Opinion Leader in the field of MS, is Head of the multi-disciplinary MS Clinic and Center at Hadassah, member of the European Steering Committee for Bone Marrow Transplantation in MS, member of the Executive Board and Scientific Committee of the European School of Neuroimmunology (ESNI), and former board member of the European Council and Committee for Treatment and Research in MS. He has been the Principal Investigator of several multi-national clinical trials in MS conducted by global pharmaceutical companies.
NurOwn is an autologous, adult stem cell therapy technology that induces bone marrow-derived mesenchymal stem cells (MSC) to secrete high levels of neurotrophic factors for protection of existing motor neurons, promotion of motor neuron growth, and re-establishment of nerve-muscle interaction. More information about NurOwn(TM) can be found at http://brainstorm-cell.com/index.php/science-a-technology/-nurown.
Over the course of the disease, multiple sclerosis is very often combined with a deteriorating memory and attention deficits. Researchers at the University Department of Radiology and Nuclear Medicine at the MedUni Vienna have now demonstrated by means of a meta-analysis of functional image data that increased activations in the involuntary attention system in the brain are responsible for these disorders in MS patients.
MS patients generally often have problems with fading out what is unimportant. Says head of the study Veronika Schöpf: "They are practically in continuous alarm mode." The attention system is too highly activated and also notices – for example when watching the television or when talking to someone – completely unimportant extraneous noises. Because of this, concentrating on what is important is completely impossible or only possible to a limited extent. In addition, MS patients find it difficult to look for one specific thing and also find it. This high activation thus also leads to a poor memory and at the same time adversely affects the ability to take in new things.
In a meta-analysis in the top journal Neuroscience & Biobehavioral Reviews(Impact Factor 9.44) it has now been possible to prove that functional changes in the brain are responsible for these disorders and that these can also be depicted by means of functional imaging.
"In most people the centre for these activities lies in the right half of the brain, in many MS patients however it lies in the left side of the brain, as it does in many epilepsy patients," says the PhD student and primary author Kathrin Kollndorfer. This knowledge could now feed into the development of personalised treatments for people with multiple sclerosis in order to counteract these cognitive disorders in good time.
With this, the working group at the MedUni Vienna has also achieved a better generalisability of the research results so far with regard to working memory and attention in patients with multiple sclerosis. "Most studies that have so far dealt with this question by means of functional imaging have mostly examined only very small and heterogeneous samples, which clearly differ with regard to age, gender or duration of illness. We have included in our evaluation everything in studies so far," explains Veronica Schöpf.
Multiple sclerosis is an incurable, chronic inflammatory disease of the central nervous system, which develops slowly at first and in later stages leads to greater and greater physical and mental handicaps. According to figures of the Austrian Multiple Sclerosis Society (ÖMSG) about 12,500 people suffer from this disease.
More information: Kollndorfer, K. et al. Altered likelihood of brain activation in attention and working memory networks in patients with multiple sclerosis: An ALE meta-analysis, Neuroscience & Biobehavioral Reviews.
To comment - click the comment link shown below
USE OUR SHARE LINKS at the top of this page - to provide this
article to others
Theoretical physicist Albert Einstein had a brain that was not only bigger in many regions, but better connected than the brains of most people, a new study has found. (The Magnes Press)
======================== By Melissa Healy
This post has been corrected. See note at bottom for details.
October 10, 2013
Albert Einstein had a colossal corpus callosum. And when it comes to this particular piece of neural real estate, it's pretty clear that size matters.
Chances are, that brawny bundle of white matter cleaving the Swiss physicist's brain from front to back is part of what made his mind so phenomenally creative. The corpus callosum carries electrical signals between the brain's right hemisphere and its left. Stretching nearly the full length of the brain from behind the forehead to the nape of the neck, the corpus callosum is the dense network of neural fibers that make brain regions with very different functions work together.
When the corpus callosum works well, the human brain is a marvel of social, spatial and verbal reasoning. When it malfunctions, as it appears to do in autism, fetal alcohol syndrome and certain genetic disorders, as well as after traumatic brain injury, the effect on cognition can be disastrous.